blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2996573

EP2996573 - LOADING DEVICES FOR PERCUTANEOUS PERFORATION CLOSURE SYSTEMS [Right-click to bookmark this link]
Former [2016/12]LOADING DEVICES AND METHODS FOR PERCUTANEOUS PERFORATION CLOSURE SYSTEMS
[2022/02]
StatusNo opposition filed within time limit
Status updated on  03.03.2023
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  25.03.2022
FormerGrant of patent is intended
Status updated on  21.12.2021
FormerExamination is in progress
Status updated on  13.07.2018
Most recent event   Tooltip27.10.2023Lapse of the patent in a contracting state
New state(s): MC
published on 29.11.2023  [2023/48]
Applicant(s)For all designated states
Vivasure Medical Limited
Parkmore Business Park West
Galway / IE
[2018/43]
Former [2016/12]For all designated states
Vivasure Medical Limited
Unit 6 Dangan IDA Business Park
Dangan, Galway / IE
Inventor(s)01 / GRANT, Peter
3 Dangan Court
Dangan Galway / IE
02 / PAWLIKOWSKI, Bartosz
Apt. 10 Cearnog Nua
Moycullen Co. Galway / IE
03 / SLATTERY, Daniel
13 Caheronaun Park
Loughrea Co. Galway / IE
04 / MURPHY, Matthew
Pembrokestown House
Pembrokestown
Whiterock Hill Wexford / IE
05 / MARTIN, Chris
Rusheeney
Oughterard Co. Galway / IE
 [2016/12]
Representative(s)Weldon O'Brien Ltd.
Shannon Lodge
Casement Road
Bandon
County Cork, P72 TN24 / IE
[2022/17]
Former [2016/12]O'Brien, John Augustine, et al
John A. O'Brien & Associates Third Floor, Duncairn House, 14 Carysfort Avenue
Blackrock, Co Dublin / IE
Application number, filing date14720252.715.03.2014
[2016/12]
WO2014IB59848
Priority number, dateUS201361789584P15.03.2013         Original published format: US 201361789584 P
[2016/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014141209
Date:18.09.2014
Language:EN
[2014/38]
Type: A1 Application with search report 
No.:EP2996573
Date:23.03.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 18.09.2014 takes the place of the publication of the European patent application.
[2016/12]
Type: B1 Patent specification 
No.:EP2996573
Date:27.04.2022
Language:EN
[2022/17]
Search report(s)International search report - published on:EP18.09.2014
ClassificationIPC:A61B17/00, A61B50/33
[2022/02]
CPC:
A61B17/0057 (EP,US); B65B39/007 (US); A61B50/33 (EP,US);
A61B2017/00477 (EP,US); A61B2017/0053 (EP,US); A61B2017/00597 (EP,US);
A61B2017/00623 (EP,US); A61B2017/00637 (EP,US); A61B2017/00654 (EP,US);
A61B2050/314 (EP,US); A61B2090/036 (EP,US); A61B2090/037 (EP,US);
Y10T29/49863 (EP,US); Y10T29/5186 (EP,US) (-)
Former IPC [2016/12]A61B17/00, A61B50/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/12]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:LADEVORRICHTUNGEN FÜR PERKUTANE PERFORATIONSVERSCHLUSSSYSTEME[2022/02]
English:LOADING DEVICES FOR PERCUTANEOUS PERFORATION CLOSURE SYSTEMS[2022/02]
French:DISPOSITIFS DE RECHARGE POUR SYSTÈMES D'OCCLUSION DE PERFORATION PERCUTANÉE[2022/02]
Former [2016/12]LADEVORRICHTUNGEN UND VERFAHREN FÜR PERKUTANE PERFORATIONSVERSCHLUSSSYSTEME
Former [2016/12]LOADING DEVICES AND METHODS FOR PERCUTANEOUS PERFORATION CLOSURE SYSTEMS
Former [2016/12]DISPOSITIFS ET PROCÉDÉS DE CHARGEMENT POUR SYSTÈMES DE FERMETURE DE PERFORATION PERCUTANÉE
Entry into regional phase09.10.2015National basic fee paid 
09.10.2015Designation fee(s) paid 
09.10.2015Examination fee paid 
Examination procedure09.10.2015Examination requested  [2016/12]
20.04.2016Amendment by applicant (claims and/or description)
13.07.2018Despatch of a communication from the examining division (Time limit: M04)
12.11.2018Reply to a communication from the examining division
08.12.2021Cancellation of oral proceeding that was planned for 18.01.2022
22.12.2021Communication of intention to grant the patent
18.01.2022Date of oral proceedings (cancelled)
22.03.2022Fee for grant paid
22.03.2022Fee for publishing/printing paid
22.03.2022Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.07.2018
Opposition(s)30.01.2023No opposition filed within time limit [2023/14]
Fees paidRenewal fee
03.03.2016Renewal fee patent year 03
08.03.2017Renewal fee patent year 04
01.02.2018Renewal fee patent year 05
07.02.2019Renewal fee patent year 06
07.01.2020Renewal fee patent year 07
08.02.2021Renewal fee patent year 08
12.01.2022Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL27.04.2022
AT27.04.2022
CZ27.04.2022
DK27.04.2022
EE27.04.2022
FI27.04.2022
HR27.04.2022
LT27.04.2022
LV27.04.2022
MC27.04.2022
NL27.04.2022
PL27.04.2022
RO27.04.2022
RS27.04.2022
SE27.04.2022
SI27.04.2022
SK27.04.2022
SM27.04.2022
BG27.07.2022
NO27.07.2022
GR28.07.2022
IS27.08.2022
PT29.08.2022
[2023/48]
Former [2023/25]AL27.04.2022
AT27.04.2022
CZ27.04.2022
DK27.04.2022
EE27.04.2022
FI27.04.2022
HR27.04.2022
LT27.04.2022
LV27.04.2022
NL27.04.2022
PL27.04.2022
RO27.04.2022
RS27.04.2022
SE27.04.2022
SI27.04.2022
SK27.04.2022
SM27.04.2022
BG27.07.2022
NO27.07.2022
GR28.07.2022
IS27.08.2022
PT29.08.2022
Former [2023/17]AL27.04.2022
AT27.04.2022
CZ27.04.2022
DK27.04.2022
EE27.04.2022
FI27.04.2022
HR27.04.2022
LT27.04.2022
LV27.04.2022
NL27.04.2022
PL27.04.2022
RO27.04.2022
RS27.04.2022
SE27.04.2022
SK27.04.2022
SM27.04.2022
BG27.07.2022
NO27.07.2022
GR28.07.2022
IS27.08.2022
PT29.08.2022
Former [2023/09]AT27.04.2022
CZ27.04.2022
DK27.04.2022
EE27.04.2022
FI27.04.2022
HR27.04.2022
LT27.04.2022
LV27.04.2022
NL27.04.2022
PL27.04.2022
RO27.04.2022
RS27.04.2022
SE27.04.2022
SK27.04.2022
SM27.04.2022
BG27.07.2022
NO27.07.2022
GR28.07.2022
IS27.08.2022
PT29.08.2022
Former [2023/07]AT27.04.2022
DK27.04.2022
FI27.04.2022
HR27.04.2022
LT27.04.2022
LV27.04.2022
NL27.04.2022
PL27.04.2022
RS27.04.2022
SE27.04.2022
BG27.07.2022
NO27.07.2022
GR28.07.2022
IS27.08.2022
PT29.08.2022
Former [2022/51]AT27.04.2022
FI27.04.2022
HR27.04.2022
LT27.04.2022
LV27.04.2022
NL27.04.2022
PL27.04.2022
RS27.04.2022
SE27.04.2022
BG27.07.2022
NO27.07.2022
GR28.07.2022
IS27.08.2022
PT29.08.2022
Former [2022/50]AT27.04.2022
FI27.04.2022
HR27.04.2022
LT27.04.2022
LV27.04.2022
NL27.04.2022
PL27.04.2022
RS27.04.2022
SE27.04.2022
BG27.07.2022
NO27.07.2022
GR28.07.2022
PT29.08.2022
Former [2022/49]AT27.04.2022
FI27.04.2022
HR27.04.2022
LT27.04.2022
LV27.04.2022
NL27.04.2022
SE27.04.2022
BG27.07.2022
NO27.07.2022
GR28.07.2022
PT29.08.2022
Former [2022/47]AT27.04.2022
FI27.04.2022
LT27.04.2022
NL27.04.2022
SE27.04.2022
NO27.07.2022
PT29.08.2022
Former [2022/44]NL27.04.2022
Cited inInternational search[X]EP0761250  (TARGET THERAPEUTICS INC [US]) [X] 1,2,7,9,11-14 * figure 4 *;
 [A]US5620461  (MUIJS VAN DE MOER WOUTER M [NL], et al) [A] 1* figure 8 *;
 [X]US5997515  (DE LA TORRE ROGER A [US], et al) [X] 1-3,6,7,9,11,14 * figures 6a,7,23 *;
 [X]US6200328  (CRAGG ANDREW H [US], et al) [X] 1-3,6,7,9,11-14 * columns 5-8; figures 2,7,8,9,10 *;
 [X]US2009012521  (AXELSON JR STUART L [US], et al) [X] 1-3,6-15 * paragraph [0024]; figures 1,4,9 *;
 [X]DE102010048908  (AESCULAP AG [DE]) [X] 1,2,4,7,11-14 * figures 1b,1c *;
 [XP]WO2013128292  (VIVASURE MEDICAL LTD [IE]) [XP] 1,2,4,6-15 * paragraphs [0395] , [0400] , [0405] , [0406] , [0418] , [0435]; figures 36-43N,59 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.